Trailing-twelve-month (TTM) revenue is $8.27 Billion with a year-over-year growth of (32.68%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $3,072,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-06 |
| Q4 FY2025Period ended 2025-12-31 | $1,693,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-17 |
| Q1 FY2026Period ended 2026-03-31 | $1,681,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-05 |
| Q2 FY2026Period ended 2026-06-30 | $1,819,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-04 |
| TTM revenue | $8,265,000,000 |
Current P/S: $17,279,731,620 market capitalization ÷ $8,265,000,000 TTM revenue = 2.09x.
Market capitalization source: FMP quote. Quote observed 2026-09-09T20:00:00.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $1.82B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-09T20:00:00.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2024-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20192019-12-31 · USD | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD |
|---|---|---|---|---|---|---|
| Corporate Segment | $1.7B | $1.3B | $502M | $1.1B | $1.1B | $1.0B |
| Electronics And Industrial Segment | $3.6B | $3.8B | $5.6B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Asia Pacific | $6.8B | $8.1B | $6.0B | $5.2B | $5.4B | $1.6B |
| CHINA | N/A | N/A | N/A |
$8.27B
$8.27 Billion
(32.68%)
vs. $12.28B a year ago (TTM)
(9.35%)
5 Year compound annual growth rate
1 Year
(32.68%)
3 Year
(12.96%)
5 Year
(9.35%)
10 Year
(15.80%)
15 Year
(12.12%)
20 Year
(8.39%)
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $6.85B | ($5.54B) | (44.70%) |
| 2024 | $12.39B | +$318.00M | +2.64% |
| 2023 | $12.07B | ($949.00M) | (7.29%) |
| 2022 | $13.02B | +$451.00M | +3.59% |
| 2021 | $12.57B | ($1.77B) | (12.36%) |
| 2020 |
TTM Growth
(32.68%)
3-Year CAGR
(12.96%)
5-Year CAGR
(9.35%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-09T20:00:00.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $5.5B |
| $5.9B |
| Mobility And Materials Segment | N/A | N/A | $5.0B | N/A | N/A | N/A |
|---|
| Nutrition And Biosciences Segment | $6.1B | $6.1B | N/A | N/A | N/A | N/A |
|---|
| Safety And Construction Segment | $5.2B | $5.0B | N/A | N/A | N/A | N/A |
|---|
| Transportation And Advanced Polymers Segment | $5.0B | $4.2B | N/A | N/A | N/A | N/A |
|---|
| Water And Protection Segment | N/A | N/A | $5.6B | $6.0B | $5.6B | $5.4B |
|---|
| N/A |
| $708M |
| EMEA | $2.8B | $3.3B | $2.2B | $2.2B | $2.1B | $1.5B |
|---|
| Latin America | $514M | $602M | $443M | $489M | $497M | $326M |
|---|
| U.S. & Canada | $4.2B | $4.6B | $4.4B | $4.2B | $4.4B | $3.4B |
|---|
| $14.34B |
| ($7.17B) |
| (33.35%) |
| 2019 | $21.51B | ($1.08B) | (4.79%) |
| 2018 | $22.59B | ($39.89B) | (63.84%) |
| 2017 | $62.48B | +$14.34B | +29.78% |
| 2016 | $48.15B | ($561.00M) | (1.15%) |
